We are live on ! Find out more
DRTS icon

Alpha Tau Medical
DRTS

20 hedge funds and large institutions have $4.11M invested in Alpha Tau Medical in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

120% more capital invested

Capital invested by funds: $1.87M → $4.11M (+$2.24M)

25% more funds holding

Funds holding: 16 → 20 (+4)

0.43% more ownership

Funds ownership: 0.94% → 1.37% (+0.43%)

Holders
20
Holders Change
+4
Holders Change %
+25%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$1.12M
2
CCP
Corbin Capital Partners
New York
+$932K
3
ACM
Atalaya Capital Management
New York
+$264K
4
GSC
Grey Street Capital
Illinois
+$83.6K
5
Morgan Stanley
Morgan Stanley
New York
+$77.8K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.04M
2
JP Morgan Chase
JP Morgan Chase
New York
-$69.5K
3
UBS Group
UBS Group
Switzerland
-$3.71K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
1
Citigroup
New York
$1.48M +$1.12M +313,657 +1,301%
CCP
2
Corbin Capital Partners
New York
$1.14M +$932K +260,109 New
ACM
3
Atalaya Capital Management
New York
$322K +$264K +73,742 New
Morgan Stanley
4
Morgan Stanley
New York
$176K +$77.8K +21,700 +117%
JP Morgan Chase
5
JP Morgan Chase
New York
$171K -$69.5K -19,397 -33%
PMG
6
ProVise Management Group
Florida
$153K – – –
Geode Capital Management
7
Geode Capital Management
Massachusetts
$145K +$23.2K +6,470 +24%
GSC
8
Grey Street Capital
Illinois
$102K +$83.6K +23,323 New
LCS
9
Levin Capital Strategies
New York
$87.4K +$71.7K +20,000 New
CWM
10
Circle Wealth Management
New Jersey
$63.4K – – –
Wells Fargo
11
Wells Fargo
California
$47.2K – – –
STA
12
Summit Trail Advisors
New York
$44.9K +$36.8K +10,270 New
FGG
13
Financial Guidance Group
Florida
$44.8K – – –
OWA
14
Opal Wealth Advisors
New York
$43.7K – – –
AWM
15
Activest Wealth Management
Florida
$28.4K +$14.5K +4,053 New
SPIA
16
Steward Partners Investment Advisory
New York
$26.4K – – –
TVWM
17
Tower View Wealth Management
Wisconsin
$24K – – –
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$7K – – –
TCM
19
Tuttle Capital Management
Connecticut
$4.83K +$43.8K +12,221 New
Bank of America
20
Bank of America
North Carolina
$3.41K – – –
Fidelity Investments
21
Fidelity Investments
Massachusetts
– -$1.04M -362,046 Closed
UBS Group
22
UBS Group
Switzerland
– -$3.71K -1,292 Closed

DRTS Hedge Fund Activity: Q2 2023 in Review

20 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q2 2023, worth a combined $4.11M — up 120% from $1.87M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DRTS positions and 2 closed out — a net gain of 5 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was Citigroup, adding an estimated $1.12M. The largest seller was Fidelity Investments, exiting entirely with an estimated $1.04M sold.

  • 20 institutional investors held Alpha Tau Medical (DRTS) as of Q2 2023, up from 16 in Q1 2023.
  • Funds reported $4.11M of Alpha Tau Medical stock for Q2 2023, up 120% quarter-over-quarter.
  • 7 funds opened new Alpha Tau Medical positions in Q2 2023 and 2 closed out, a net change of +5 holders.
  • The largest Alpha Tau Medical buyer in Q2 2023 was Citigroup, an estimated $1.12M added.
  • The largest Alpha Tau Medical seller in Q2 2023 was Fidelity Investments, an estimated $1.04M sold.

Based on aggregated 13F filings for Q2 2023.